Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125524
Filing Date
2024-11-12
Accepted
2024-11-12 16:30:30
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q iobt-20240930.htm   iXBRL 10-Q 1957249
2 EX-31.1 iobt-ex31_1.htm EX-31.1 16727
3 EX-31.2 iobt-ex31_2.htm EX-31.2 16601
4 EX-32.1 iobt-ex32_1.htm EX-32.1 9257
5 EX-32.2 iobt-ex32_2.htm EX-32.2 9134
6 GRAPHIC img134952283_0.jpg GRAPHIC 85197
7 GRAPHIC img134952283_1.jpg GRAPHIC 363670
  Complete submission text file 0000950170-24-125524.txt   7434664

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iobt-20240930.xsd EX-101.SCH 857604
68 EXTRACTED XBRL INSTANCE DOCUMENT iobt-20240930_htm.xml XML 793350
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 241448894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)